STUB1 pathway may protect neurons after spinal cord injury

A China-led research team found that the protein STUB1 helps neurons resist ferroptosis after traumatic spinal cord injury by preserving SIRT6 and activating NRF2-driven antioxidant defenses. The preclinical study, published July 6, 2026, points to a possible new target for reducing secondary spinal cord damage, though the findings have only been tested in cells and mice.

Why it matters: - Traumatic spinal cord injury often gets worse after the initial hit because secondary damage keeps killing surviving neurons. - Ferroptosis, an iron-driven form of cell death, is a major part of that secondary injury. - A pathway that blocks ferroptosis could help preserve neurons, limit tissue loss and improve motor recovery after injury.

What happened: - Researchers from the First Affiliated Hospital of the University of Science and Technology of China and the First Affiliated Hospital of Nanjing Medical University published the study online July 6, 2026, in Burns & Trauma. - The paper identified STUB1 as an upstream protein that stabilizes SIRT6, which then activates NRF2-dependent antioxidant defenses. - The study used cultured primary neurons, a mouse spinal cord injury model and NRF2-deficient mice. - The article is available through the original study DOI.

The details: - After spinal cord injury, the researchers saw early increases in iron, lipid peroxidation and oxidative stress, along with lower SIRT6 levels. - Ferrostatin-1, a ferroptosis inhibitor, improved functional measures in the injury model, supporting ferroptosis as a modifiable driver of damage. - Increasing SIRT6 in primary neurons reduced ferroptotic injury, preserved mitochondrial structure and improved cell survival. - Reducing SIRT6 had the opposite effect. - In injured mice, neuron-targeted adeno-associated virus delivery of SIRT6 improved Basso Mouse Scale scores, rotarod performance, walking patterns and motor evoked potentials. - SIRT6 delivery also increased surviving neurons and axons near the lesion. - Immunoprecipitation, mass spectrometry and co-immunoprecipitation showed that SIRT6 binds to NRF2 and removes acetyl groups. - That deacetylation helped NRF2 move into the nucleus and turn on antioxidant genes. - STUB1 was identified as an upstream partner of SIRT6. - STUB1 added K63-linked ubiquitin chains that stabilized SIRT6 instead of sending it to proteasomal destruction. - STUB1 overexpression reduced ferroptosis and improved recovery. - Those benefits weakened when SIRT6 was suppressed and disappeared in NRF2-deficient mice.

Between the lines: - The study links a specific protein network to measurable recovery outcomes, not just cell-survival signals. - The loss-of-function experiments strengthen the causal case that STUB1, SIRT6 and NRF2 work together in the same protective pathway. - The findings also fit a larger pattern in spinal cord injury research: protecting neurons early may matter as much as repairing damage later.

What's next: - The authors say the pathway could guide future therapies that stabilize SIRT6, boost protective K63-linked ubiquitination or strengthen NRF2 activity during the early secondary-injury window. - The work remains preclinical and was done mainly in cultured neurons and mice. - Future studies need to test timing, delivery methods, long-term safety and whether the pathway improves outcomes in larger animals. - Human spinal cord tissue studies will also be needed before clinical translation.

The bottom line: - STUB1 may act as a neuronal shield after spinal cord injury by preserving SIRT6 and keeping NRF2-based antioxidant defenses active.